Previous close | 0.9700 |
Open | 1.2100 |
Bid | 1.1000 |
Ask | 1.3200 |
Strike | 95.00 |
Expiry date | 2025-06-20 |
Day's range | 1.2100 - 1.3200 |
Contract range | N/A |
Volume | |
Open interest | 95 |
RAHWAY, N.J., June 28, 2024--CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults
Merck stock tumbled under its 50-day moving average Thursday after the FDA rejected its Daiichi Sankyo-partnered cancer drug.
Merck's (NYSE:MRK) stock is up by 2.7% over the past week. Given that the markets usually pay for the long-term...